Company / Operating Income
Enveric Biosciences, Inc. Operating Income History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$7.1M
FY2019
5-year range
-$10.9M / -$5.4M
FY2017-FY2019
Trend
+34.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$5M to -$7M over the past 2 years.
Based on SEC 10-K filings.
-$7M in FY2019.
Declined from -$5M to -$7M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income increased 34.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$7.1M | +34.4% |
| FY2018 | -$10.9M | -102.5% |
| FY2017 | -$5.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026